The use of immunotherapy for the prevention of opportunistic gram-negative infections.
D000818:Animals; D000906:Antibodies; D000941:Antigens; D001419:Bacteria / Q000276:immunology*; D001424:Bacterial Infections / Q000517:prevention & control*; D001428:Bacterial Vaccines; D003520:Cyclophosphamide / Q000494:pharmacology; D005069:Evaluation Studies as Topic; D007106:Immune Sera; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D007165:Immunosuppression Therapy; D007710:Klebsiella Infections / Q000517:prevention & control; D011512:Proteus Infections / Q000517:prevention & control; D011552:Pseudomonas Infections / Q000517:prevention & control; D011817:Rabbits; D012705:Serratia / Q000276:immunology; D014611:Vaccination
D000906:Antibodies; D000941:Antigens; D001428:Bacterial Vaccines; D007106:Immune Sera; D003520:Cyclophosphamide